Page last updated: 2024-09-03

lestaurtinib and isotretinoin

lestaurtinib has been researched along with isotretinoin in 1 studies

Compound Research Comparison

Studies
(lestaurtinib)
Trials
(lestaurtinib)
Recent Studies (post-2010)
(lestaurtinib)
Studies
(isotretinoin)
Trials
(isotretinoin)
Recent Studies (post-2010) (isotretinoin)
12412634,0645061,216

Protein Interaction Comparison

ProteinTaxonomylestaurtinib (IC50)isotretinoin (IC50)
Adenosine receptor A3Homo sapiens (human)4.169
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)4.169
Alpha-2B adrenergic receptorHomo sapiens (human)6.612
Mitogen-activated protein kinase 1Homo sapiens (human)0.462
Cellular retinoic acid-binding protein 1Gallus gallus (chicken)0.9
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.848
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)4.169
Mitogen-activated protein kinase 14Homo sapiens (human)2.529
Olfactory receptor 51E2Homo sapiens (human)0.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamson, PC; Brodeur, GM; Maris, JM; Minturn, JE; Norris, RE1

Other Studies

1 other study(ies) available for lestaurtinib and isotretinoin

ArticleYear
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:6

    Topics: Antineoplastic Agents; Brain Neoplasms; Carbazoles; Cell Line, Tumor; Drug Evaluation, Preclinical; Fenretinide; Furans; Humans; Isotretinoin; Neuroblastoma; Receptor, trkB

2011